Gastrointestinal Medications - PPIs, H2-Blockers, Antiemetics, Antispasmodics
The gastrointestinal (GI) system — from the oesophagus through stomach, small and large intestine, to the rectum — is the most complex organ system in the body after the brain. GI complaints account for an estimated 10% of all primary care consultations worldwide. This catalogue covers the full pharmacological spectrum: acid suppression for reflux and ulcers, antiemetics for nausea and vomiting, antispasmodics for IBS, prokinetics for gastroparesis, antidiarrhoeal agents, laxatives for constipation, and therapies for inflammatory bowel disease.
Modern GI pharmacotherapy has been transformed by several breakthroughs: proton pump inhibitors (PPIs) in the late 1980s essentially eliminated the need for ulcer surgery; H. pylori eradication regimens in the 1990s cured the bacterial cause of most peptic ulcers; biologics in the 2000s revolutionised inflammatory bowel disease management; and 5-HT3 antagonists made chemotherapy-induced vomiting much more manageable.
Choosing the right GI medication depends on specific diagnosis, symptom duration and severity, alarm features (weight loss, GI bleeding, dysphagia), age, pregnancy status, and renal function. Many GI symptoms can be treated empirically, but persistent symptoms or alarm features always warrant further investigation including endoscopy and laboratory testing to exclude serious pathology.
Conditions This Category Treats
Gastroesophageal reflux disease (GERD) affects up to 20% of adults in Western populations, causing heartburn, regurgitation, chronic cough, hoarseness, and in severe cases oesophageal stricture or Barrett oesophagus (pre-malignant change). Treatment is layered: lifestyle (weight loss, elevation of bed head, avoiding late meals) plus proton pump inhibitors (Nexium / esomeprazole, Prilosec / omeprazole, Aciphex / rabeprazole), occasionally adding H2 blockers (Pepcid / famotidine) or alginates for breakthrough symptoms.
Peptic ulcer disease affects roughly 4 million people annually. The two main causes are Helicobacter pylori infection and NSAID use. H. pylori eradication uses 14-day combination of two antibiotics plus a PPI (clarithromycin-amoxicillin-PPI or bismuth quadruple regimen). NSAID-related ulcers are prevented and healed with PPI cover. Inflammatory bowel disease (IBD) — ulcerative colitis and Crohn disease — uses 5-aminosalicylates (sulfasalazine / Azulfidine, mesalamine), corticosteroids, immunomodulators (azathioprine, methotrexate), and increasingly biologics. Irritable bowel syndrome (IBS) affects 10-15% of adults and responds to antispasmodics (Bentyl / dicyclomine), dietary modification (low-FODMAP), and sometimes low-dose tricyclic antidepressants.
Nausea and vomiting have many causes: chemotherapy, post-operative, motion sickness, pregnancy hyperemesis, gastroparesis, and acute gastroenteritis. Zofran (ondansetron) — a 5-HT3 receptor antagonist — is highly effective for chemotherapy-induced and post-operative nausea. Reglan (metoclopramide) and Motilium (domperidone) are prokinetic dopamine antagonists that accelerate gastric emptying, useful for gastroparesis and diabetic dyspepsia. Diarrhoea responds to Imodium (loperamide) for symptom control, with antibiotics or rehydration salts for specific causes. Constipation responds to bulk-forming agents, osmotic laxatives, and prokinetics. The catalogue also covers gallstone dissolution (Actigall / ursodiol), helminth infections (Pinworm Drugs), and other specialty agents.
💊 How Modern GI Treatment Works
Proton pump inhibitors (PPIs) — the most widely prescribed GI drug class globally — bind covalently to the H+/K+ ATPase ("proton pump") in gastric parietal cells, irreversibly inhibiting acid secretion until new pumps are synthesised. This produces profound and durable acid suppression: a single morning dose maintains gastric pH above 4 for 16-20 hours. PPIs heal 90%+ of duodenal ulcers within 4 weeks and 80%+ of gastric ulcers within 8 weeks. Long-term safety concerns (increased risk of C. difficile, pneumonia, fractures, B12 deficiency, kidney injury) exist but are mostly modest in absolute terms; benefits outweigh risks for clear indications.
5-HT3 receptor antagonists like Zofran (ondansetron) block serotonin receptors in the chemoreceptor trigger zone (brainstem) and vagal afferents from the gut. This blocks the most powerful pathway of chemotherapy-induced and post-operative emesis. Dopamine antagonist prokinetics (metoclopramide, domperidone) accelerate gastric emptying by stimulating muscarinic receptors and antagonising dopamine D2 in the gut, while also reducing nausea via central anti-dopaminergic effects. Anticholinergic antispasmodics (dicyclomine, hyoscyamine) reduce smooth muscle contractility in the gut, useful for IBS cramping but cause dry mouth, blurred vision, and urinary retention as predictable side effects.
5-aminosalicylates (sulfasalazine, mesalamine) deliver topical anti-inflammatory action to the colon for ulcerative colitis. They reduce inflammation via inhibition of pro-inflammatory mediators in the colonic mucosa. Loperamide activates mu-opioid receptors in the gut to slow motility and reduce stool frequency without significant central effects (does not cross the blood-brain barrier at therapeutic doses). Bismuth subsalicylate coats the stomach and intestine, has mild antibacterial effect, and is used in traveller diarrhoea and H. pylori quadruple therapy.
💊 Drug Classes in This Category
| Class | Best For | Examples |
|---|---|---|
| Proton pump inhibitors | GERD, peptic ulcer, NSAID ulcer prevention, H. pylori eradication | Nexium (esomeprazole), Prilosec (omeprazole), Aciphex (rabeprazole) |
| H2 blockers | Mild GERD, on-demand symptom control, PPI add-on for night-time breakthrough | Pepcid (famotidine) |
| 5-HT3 antagonists (antiemetic) | Chemo-induced nausea, post-op, severe pregnancy nausea (off-label) | Zofran (ondansetron) |
| Prokinetics | Gastroparesis, GERD with delayed emptying, dyspepsia, lactation support (domperidone) | Reglan (metoclopramide), Motilium (domperidone) |
| Antispasmodics | IBS cramping, intestinal spasm, painful bowel syndrome | Bentyl (dicyclomine) |
| 5-ASA / IBD therapy | Ulcerative colitis induction and maintenance; mild Crohn | Azulfidine (sulfasalazine) |
| Antidiarrhoeals | Acute diarrhoea, IBS-D, post-resection, ileostomy output reduction | Imodium (loperamide) |
| Gallstone dissolution | Small cholesterol gallstones; primary biliary cirrhosis | Actigall (ursodiol) |
✅ How to Choose
- 🔥 Frequent heartburn or acid reflux → Nexium 40 mg or Prilosec 20 mg once daily before breakfast for 4-8 weeks. Step down to lowest effective dose for chronic management.
- 🪻 Peptic ulcer (suspected or confirmed) → PPI 4-8 weeks + test for H. pylori (urea breath test or stool antigen). If positive, eradication therapy.
- 🪴 Acute traveller diarrhoea → Imodium 4 mg initially, then 2 mg after each loose stool, plus oral rehydration. Avoid in bloody diarrhoea or high fever (need investigation).
- 🫠 Chemo-induced or post-op nausea → Zofran (ondansetron) 4-8 mg orally or sublingually — remarkably effective with minimal sedation.
- 🍭 Diabetic gastroparesis or chronic dyspepsia → Reglan 10 mg before meals and at bedtime. Limit to short courses due to tardive dyskinesia risk.
- 🍩 IBS with cramping → Bentyl (dicyclomine) 10-20 mg before meals; combine with dietary modification (low-FODMAP).
- 🤯 Ulcerative colitis (mild-moderate) → Azulfidine (sulfasalazine) 2-4 g daily in divided doses; folate supplementation alongside.
❓ Frequently Asked Questions about GI Medications
What is the difference between PPIs and H2 blockers?
Both reduce stomach acid but through different mechanisms and to different degrees. PPIs (Nexium, Prilosec, Aciphex) irreversibly inhibit the proton pump, producing profound acid suppression for 16-20 hours per dose. H2 blockers (Pepcid / famotidine) competitively block H2 histamine receptors on parietal cells, producing moderate acid reduction. PPIs are stronger and better for healing ulcers; H2 blockers act faster and are useful for on-demand symptom relief.
Should I take my PPI in the morning or evening?
30-60 minutes before breakfast is the standard. PPIs work best when active proton pumps are stimulated by food after a meal. Twice-daily dosing for severe symptoms or healing ulcers: morning and evening dose 30-60 minutes before respective meals. Bedtime H2 blocker can supplement PPI for night-time breakthrough.
Why does Imodium not work for bloody diarrhoea?
Imodium slows gut motility, but in invasive bacterial diarrhoea (Shigella, Salmonella, enteroinvasive E. coli, C. difficile), slowing the gut traps the pathogen in contact with the mucosa longer, potentially worsening systemic toxicity. Bloody diarrhoea, high fever, or severe systemic illness warrant evaluation and stool testing before symptomatic treatment.
Is it safe to take Zofran during pregnancy?
Ondansetron is widely used for severe pregnancy nausea (hyperemesis gravidarum) when other options fail. Most studies show no significant teratogenic risk; some older studies suggested very small increases in cardiac defects, not consistently replicated. Risk-benefit balance favours use for moderate-severe pregnancy nausea. Discuss with your obstetric provider.
How long does H. pylori eradication take?
Standard regimens are 10-14 days. First-line in most regions is clarithromycin-based triple therapy (PPI + clarithromycin + amoxicillin) or quadruple therapy (PPI + bismuth + metronidazole + tetracycline). Cure rates vary by local resistance — 80-90% with first attempt. Test of cure (urea breath test or stool antigen) should be done at least 4 weeks after completion and 2 weeks off PPI.
When should I see a doctor for digestive symptoms?
Urgent evaluation for: unintentional weight loss, persistent vomiting, vomiting blood or coffee-ground material, bloody or black tarry stool, difficulty swallowing, severe persistent abdominal pain, palpable abdominal mass, jaundice, or symptoms persisting over 4-6 weeks despite treatment. Anyone over 50 with new dyspepsia warrants endoscopy. Family history of GI cancer warrants earlier screening.
🩺 When to See a Healthcare Provider
The GI tract has serious diseases that can mimic benign ones. Stomach and oesophageal cancer can present with mild reflux-like symptoms; colorectal cancer may present as constipation or change in bowel habit; inflammatory bowel disease can flare quietly and cause significant damage before diagnosis. Routine screening colonoscopy from age 45-50 (earlier with family history) reduces colorectal cancer mortality by approximately 25-30%. Investigation is also warranted for persistent symptoms despite empirical therapy.
Tell your prescriber about all medications including over-the-counter NSAIDs, aspirin, anticoagulants, bisphosphonates, and steroids — all increase GI bleeding or ulcer risk. PPIs interact with clopidogrel (reduce antiplatelet effect for some PPI / patient combinations), warfarin, and digoxin. Pregnancy planning, recent travel, recent antibiotic use, and family history all influence management. Symptoms persisting beyond 4-8 weeks of empirical therapy require investigation rather than refilled prescriptions.